NCT00346229View on ClinicalTrials.gov

Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Breast Cancer
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

pegfilgrastim

DRUG

lyso-thermosensitive liposomal doxorubicin(Thermodox)

PROCEDURE

hyperthermia treatment

Trial Locations (1)

27710

Duke Cancer Institute, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER